Núria Viñolas
Hospital Clínic de Barcelona · 230 works · 7,311 citations · h-index 41
Top works
- Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
- Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
- Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance
- Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer
- Cancer diagnosis disclosure in a Spanish hospital
- Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma
- miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
- Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas
- Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages.
- Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Determined by Promoter Hypermethylation and Immunohistochemical Expression in Anaplastic Gliomas
- Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)
- Serum immunoglobulins in B-chronic lymphocytic leukemia.Natural history and prognostic significance
- Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial
- Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trial
- Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer
- Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions
- Efficacy of radiotherapy for malignant gliomas in elderly patients
- Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
- Recombinant alpha 2-interferon in the treatment of B chronic lymphocytic leukemia in early stages
- Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung Cancer